Cardiovascular prevention in South Asian populations

Thanks for the question—there’s a wording gap here. There aren’t clinical outcome trials on “Brown Hearts” as a defined intervention or program in cardiovascular prevention. If by “Brown” you mean South Asian hearts (i.e., cardiometabolic prevention in South Asian populations), there are important data, but not many large, South-Asian–only randomized outcome trials. What we do have: strong outcome evidence for LDL lowering (statins, ezetimibe, PCSK9), BP control, smoking cessation, and diabetes management that applies across ethnicities, plus cohort studies showing South Asians develop ASCVD younger with higher plaque burden at lower BMI/waist. If you meant a specific product or initiative named “Brown Hearts,” share details and I’ll assess the evidence.